Bone defects in LPA receptor genetically modified mice

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 93-98

  Salles, Jean Pierre ^a,b   Laurencin Dalicieux, Sara ^b   Conte Auriol, Françoise ^a,b   Briand Mésange, Fabienne ^b   Gennero, Isabelle ^a,c  

^a HÔPITAL DES ENFANTS   (France)

^b University of Toulouse III   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Bone resorption; LPA1; Lysophosphatidic acid; Osteogenesis; Osteoporosis; Parathyroid hormone related peptide

Indexed keywords

AUTOTAXIN; LYSOPHOSPHATIDIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE DEFECT; BONE DEVELOPMENT; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; CORTICAL BONE; DNA MODIFICATION; HEMATOPOIETIC STEM CELL; HISTOLOGY; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STERNUM; TRABECULAR BONE;

ANIMALS; BONE AND BONES; LYSOPHOSPHOLIPIDS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OSTEOBLASTS; PHENOTYPE; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 84868591061     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.07.018     Document Type: Review

References (56)

1. H.M. Kronenberg Developmental regulation of the growth plate Nature 423 2003 332 336
2. L.J. Raggatt, and N.C. Partridge Cellular and molecular mechanisms of bone remodeling J. Biol. Chem. 285 2010 25103 25108
3. R.S. Tare, J.C. Babister, J. Kanczler, and R.O. Oreffo Skeletal stem cells: phenotype, biology and environmental niches informing tissue regeneration Mol. Cell. Endocrinol. 288 2008 11 21
4. G. Karsenty Transcriptional control of skeletogenesis Annu. Rev. Genomics Hum. Genet. 9 2008 183 196
5. J. Blackburn, and J.P. Mansell The emerging role of lysophosphatidic acid (LPA) in skeletal biology Bone 50 2012 756 762
6. Y.B. Liu, Y. Kharode, P.V. Bodine, P.J. Yaworsky, J.A. Robinson, and J. Billiard LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4 J. Cell. Biochem. 109 2010 794 800
7. R. Dziak, B.M. Yang, B.W. Leung, S. Li, N. Marzec, J. Margarone, and L. Bobek Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells Prostaglandins Leukot. Essent. Fatty Acids 68 2003 239 249
8. A. Grey, T. Banovic, D. Naot, B. Hill, K. Callon, I. Reid, and J. Cornish Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases Endocrinology 142 2001 1098 1106
9. J.P. Mansell, M. Nowghani, M. Pabbruwe, I.C. Paterson, A.J. Smith, and A.W. Blom Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA Prostaglandins Other Lipid Mediat. 95 2011 45 52
10. L.M. Masiello, J.S. Fotos, D.S. Galileo, and N.J. Karin Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells Bone 39 2006 72 82
11. J.P. Salles, I. Gennero, C. Cariven, H. Chap, and M. Tauber Effect of lysophosphatidic acid on trophicity of osteoblats: study with rat UMR 106.1 cells and human osteoblats Pediatr. Res. 49 2001 22A (abst)
12. I. Gennero, S. Laurencin-Dalicieux, F. Conte-Auriol, F. Briand-Mesange, D. Laurencin, J. Rue, N. Beton, N. Malet, M. Mus, A. Tokumura, P. Bourin, L. Vico, G. Brunel, R.O. Oreffo, J. Chun, and J.P. Salles Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass Bone 49 2011 395 403
13. N. Panupinthu, J.T. Rogers, L. Zhao, L.P. Solano-Flores, F. Possmayer, S.M. Sims, and S.J. Dixon P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis J. Cell Biol. 181 2008 859 871
14. N. Panupinthu, L. Zhao, F. Possmayer, H.Z. Ke, S.M. Sims, and S.J. Dixon P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid J. Biol. Chem. 282 2007 3403 3412
15. S.A. Karagiosis, and N.J. Karin Lysophosphatidic acid induces osteocyte dendrite outgrowth Biochem. Biophys. Res. Commun. 357 2007 194 199
16. K.M. Waters, J.M. Jacobs, M.A. Gritsenko, and N.J. Karin Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: relevance to dendrite outgrowth Bone 48 2011 1328 1335
17. J. Gidley, S. Openshaw, E.T. Pring, S. Sale, and J.P. Mansell Lysophosphatidic acid cooperates with 1alpha,25(OH)2D3 in stimulating human MG63 osteoblast maturation Prostaglandins Other Lipid Mediat. 80 2006 46 61
18. J.P. Mansell, M. Barbour, C. Moore, M. Nowghani, M. Pabbruwe, T. Sjostrom, and A.W. Blom The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces Biomaterials 31 2010 199 206
19. J.P. Mansell, D. Farrar, S. Jones, and M. Nowghani Cytoskeletal reorganisation, 1alpha,25-dihydroxy vitamin D3 and human MG63 osteoblast maturation Mol. Cell. Endocrinol. 305 2009 38 46
20. J.P. Mansell, J. Brown, J.G. Knapp, C.F. Faul, and A.W. Blom Lysophosphatidic acid-functionalised titanium as a superior surface for supporting human osteoblast (MG63) maturation Eur. Cells Mater. 23 2012 348 361
21. G. Tigyi Aiming drug discovery at lysophosphatidic acid targets Br. J. Pharmacol. 161 2010 241 270
22. A. Schindeler, and D.G. Little Ras-MAPK signaling in osteogenic differentiation: friend or foe? J. Bone Miner. Res. 21 2006 1331 1338
23. H.S. Sul Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate Mol. Endocrinol. 23 2009 1717 1725
24. D.M. Lapierre, N. Tanabe, A. Pereverzev, M. Spencer, R.P.P. Shugg, S.J. Dixon, and S.M. Sims Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival J. Biol. Chem. 285 2010 25792 25801
25. A. Boucharaba, B. Guillet, F. Menaa, M. Hneino, A.J. van Wijnen, P. Clezardin, and O. Peyruchaud Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms Oncol. Res. 18 2009 173 184
26. A. Boucharaba, C.M. Serre, S. Gres, J.S. Saulnier-Blache, J.C. Bordet, J. Guglielmi, P. Clezardin, and O. Peyruchaud Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J. Clin. Invest. 114 2004 1714 1725
27. A. Boucharaba, C.M. Serre, J. Guglielmi, J.C. Bordet, P. Clezardin, and O. Peyruchaud The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases Proc. Natl. Acad. Sci. U. S. A. 103 2006 9643 9648
28. O. Fourcade, M.F. Simon, C. Viode, N. Rugani, F. Leballe, A. Ragab, B. Fournie, L. Sarda, and H. Chap Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells Cell 80 1995 919 927
29. F. Gaits, O. Fourcade, F. Le Balle, G. Gueguen, B. Gaige, A. Gassama-Diagne, J. Fauvel, J.P. Salles, G. Mauco, M.F. Simon, and H. Chap Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis FEBS Lett. 410 1997 54 58
30. G. Mauco, H. Chap, M.F. Simon, and L. Douste-Blazy Biochimie 60 1978 653 661
31. J.M. Hock, V. Krishnan, J.E. Onyia, J.P. Bidwell, J. Milas, and D. Stanislaus Osteoblast apoptosis and bone turnover J. Bone Miner. Res. 16 2001 975 984
32. M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux, J. Ribeiro, C.M. Serre, S. Gres, N. Bendriss-Vermare, M. Bollen, S. Saez, J. Aoki, J.S. Saulnier-Blache, P. Clezardin, and O. Peyruchaud Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts PLoS One 5 2010 e9741
33. D. Bachner, M. Ahrens, N. Betat, D. Schroder, and G. Gross Developmental expression analysis of murine autotaxin ATX Mech. Dev. 84 1999 121 125
34. H. Ohuchi, Y. Hayashibara, H. Matsuda, M. Onoi, M. Mitsumori, M. Tanaka, J. Aoki, H. Arai, and S. Noji Diversified expression patterns of autotaxin, a gene for phospholipid-generating enzyme during mouse and chicken development Dev. Dyn. 236 2007 1134 1143
35. J.J. Contos, N. Fukushima, J.A. Weiner, D. Kaushal, and J. Chun Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior Proc. Natl. Acad. Sci. U. S. A. 97 2000 13384 13389
36. I. Gay, Z. Schwartz, V.L. Sylvia, and B.D. Boyan Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix Biochim. Biophys. Acta 1684 2004 18 28
37. B.D. Boyan, J. Hurst-Kennedy, T.A. Denison, and Z. Schwartz 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hypertrophic cells J. Steroid Biochem. Mol. Biol. 121 2010 212 216
38. J. Hurst-Kennedy, B.D. Boyan, and Z. Schwartz Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes Biochim. Biophys. Acta 1793 2009 836 846
39. J. Hurst-Kennedy, M. Zhong, V. Gupta, B.D. Boyan, and Z. Schwartz 24R,25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: a signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis J. Steroid Biochem. Mol. Biol. 122 2010 264 271
40. H.J. Kim, J.D. Delaney, and T. Kirsch The role of pyrophosphate/phosphate homeostasis in terminal differentiation and apoptosis of growth plate chondrocytes Bone 47 2010 657 665
41. J.P. Mansell, and J. Blackburn Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1alpha,25-Dihydroxyvitamin D3 (calcitriol) Biochim Biophys Acta 2012 2012
42. E.C. Hsiao, B.M. Boudignon, W.C. Chang, M. Bencsik, J. Peng, T.D. Nguyen, C. Manalac, B.P. Halloran, B.R. Conklin, and R.A. Nissenson Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass Proc. Natl. Acad. Sci. U. S. A. 105 2008 1209 1214
43. E.C. Hsiao, S.M. Millard, A. Louie, Y. Huang, B.R. Conklin, and R.A. Nissenson Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation Mol. Endocrinol. 24 2010 621 631
44. J.Y. Wu, P. Aarnisalo, M. Bastepe, P. Sinha, K. Fulzele, M.K. Selig, M. Chen, I.J. Poulton, L.E. Purton, N.A. Sims, L.S. Weinstein, and H.M. Kronenberg Gsalpha enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice J. Clin. Invest. 121 2011 3492 3504
45. S.M. Millard, A.M. Louie, L. Wattanachanya, T.J. Wronski, B.R. Conklin, and R.A. Nissenson Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation J. Bone Miner. Res. 26 2011 822 832
46. J. Peng, M. Bencsik, A. Louie, W. Lu, S. Millard, P. Nguyen, A. Burghardt, S. Majumdar, T.J. Wronski, B. Halloran, B.R. Conklin, and R.A. Nissenson Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia Endocrinology 149 2008 1329 1337
47. S. Graham, Z. Gamie, I. Polyzois, A.A. Narvani, K. Tzafetta, E. Tsiridis, M. Helioti, and A. Mantalaris Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence Expert Opin. Investig. Drugs 18 2009 746 766
48. T.K. Sampath, P. Simic, R. Sendak, N. Draca, A.E. Bowe, S. O'Brien, S.C. Schiavi, J.M. McPherson, and S. Vukicevic Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats J. Bone Miner. Res. 22 2007 849 859
49. A. Sophocleous, E. Landao-Bassonga, R.J. Van't Hof, A.I. Idris, and S.H. Ralston The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation Endocrinology 152 2011 2141 2149
50. J.J. Wysolmerski Parathyroid hormone-related protein: an update J. Clin. Endocrinol. Metab. 2012 (Electronic publication ahead of print)
51. V.K. Yadav, J.H. Ryu, N. Suda, K.F. Tanaka, J.A. Gingrich, G. Schutz, F.H. Glorieux, C.Y. Chiang, J.D. Zajac, K.L. Insogna, J.J. Mann, R. Hen, P. Ducy, and G. Karsenty Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum Cell 135 2008 825 837
52. L.S. Weinstein, J. Liu, A. Sakamoto, T. Xie, and M. Chen Minireview: GNAS: normal and abnormal functions Endocrinology 145 2004 5459 5464
53. C.W. Lee, R. Rivera, A.E. Dubin, and J. Chun LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation J. Biol. Chem. 282 2007 4310 4317
54. J.T. Swarthout, R.C. D'Alonzo, N. Selvamurugan, and N.C. Partridge Parathyroid hormone-dependent signaling pathways regulating genes in bone cells Gene 282 2002 1 17
55. K. Letellier, B. Azeddine, S. Parent, H. Labelle, P.H. Rompre, A. Moreau, and F. Moldovan Estrogen cross-talk with the melatonin signaling pathway in human osteoblasts derived from adolescent idiopathic scoliosis patients J. Pineal Res. 45 2008 383 393
56. V.K. Yadav, F. Oury, N. Suda, Z.-W. Liu, X.-B. Gao, C. Confavreux, K.C. Klemenhagen, K.F. Tanaka, J.A. Gingrich, X.E. Guo, L.H. Tecott, J.J. Mann, R. Hen, T.L. Horvath, and G. Karsenty A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure Cell 138 2009 976 989